Description

1. CSIR-Central Drug Research Institute welcomes the corporates to contribute CSR funds to following R&D areas and societal activities:
a). R&D geared towards affordable healthcare for all
b). Diseases that disproportionately affect vulnerable sections
c). Drug Repurposing, neglected diseases & drug resistance
d). Biosimilar and biotherapeutics development
e). Partnerships in use of Artificial Intelligence (AI) approaches in drug discovery and development
f). Support for outreach activity in areas of mutual interest.

Registration of Entities for undertaking CSR activities ^New

2. The Ministry of Corporate Affairs notification published in the Gazette of India Extraordinary, are given below for ready reference.